biguanides has been researched along with Hypopharyngeal Neoplasms in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Hypopharyngeal Neoplasms: Tumors or cancer of the HYPOPHARYNX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yip, KW | 1 |
| Ito, E | 1 |
| Mao, X | 1 |
| Au, PY | 1 |
| Hedley, DW | 1 |
| Mocanu, JD | 1 |
| Bastianutto, C | 1 |
| Schimmer, A | 1 |
| Liu, FF | 1 |
1 other study available for biguanides and Hypopharyngeal Neoplasms
| Article | Year |
|---|---|
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biguanide | 2006 |